WallStreetZen

NASDAQ: LIFE
aTYR PHARMA INC Stock

$10.25-2.23 (-17.87%)
Updated Sep 24, 2021
LIFE Price
$10.25
Fair Value Price
$10.39
Market Cap
$173.43M
52 Week Low
$2.93
52 Week High
$13.10
P/E
-4.48x
P/B
4.23x
P/S
35.76x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.20M
Earnings
-$29.07M
Gross Margin
100%
Operating Margin
-1,320.9%
Profit Margin
-1,320.9%
Debt to Equity
0.2
Operating Cash Flow
-$24M
Beta
0.87
Next Earnings
Nov 10, 2021
Ex-Dividend
N/A
Next Dividend
N/A

LIFE Overview

Zen Score

High
Medium
Low
33
Industry average

Reasons for this score

LIFE ($10.25) is undervalued by 1.31% relative to our estimate of its Fair Value price of $10.39 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Valuation
LIFE is good value based on its book value relative to its share price (4.23x), compared to the US Biotechnology industry average (7.01x)
Valuation
LIFE's cash and short-term investments ($44.06M) can cover LIFE's cash burn for the next year ($24.59M), even accounting for increasing cash burn (72.87%)
Financials

1 of 7

LIFE News

Valuation

LIFE fair value

Fair Value of LIFE stock based on Discounted Cash Flow (DCF)
Price
$10.25
Fair Value
$10.39
Undervalued by
1.31%
LIFE ($10.25) is undervalued by 1.31% relative to our estimate of its Fair Value price of $10.39 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Valuation

LIFE price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-4.48x
Industry
245.7x
Market
-9.09x

LIFE price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
4.23x
Industry
7.01x
LIFE is good value based on its book value relative to its share price (4.23x), compared to the US Biotechnology industry average (7.01x)
Valuation

LIFE's financial health

Profit margin

Revenue
$0.0
Net Income
-$10.4M
Profit Margin
0%
LIFE's cash and short-term investments ($44.06M) can cover LIFE's cash burn for the next year ($24.59M), even accounting for increasing cash burn (72.87%)
Financials
LIFE's profit margin has decreased (-1,130.8%) in the last year from (-190.1%) to (-1,320.9%)
Financials

Assets to liabilities

Assets
$49.0M
Liabilities
$8.2M
Debt to equity
0.04
LIFE's short-term assets ($46.41M) exceed its short-term liabilities ($7.28M)
Financials
LIFE's short-term assets ($46.41M) exceed its long-term liabilities ($906.00k)
Financials
LIFE's debt has increased relative to shareholder equity (0.2), over the past 5 years ago (0.16)
Financials
LIFE's debt to equity ratio (0.2) is considered acceptable
Financials

Cash flow

Operating
-$7.7M
Investing
-$4.0M
Financing
$1.3M
LIFE's cash and short-term investments ($44.06M) can cover LIFE's cash burn ($24.59M) for at least 1 year
Financials

aTYR PHARMA Stock FAQ

What is aTYR PHARMA's quote symbol?

(NASDAQ: LIFE) aTYR PHARMA trades on the NASDAQ under the ticker symbol LIFE. aTYR PHARMA stock quotes can also be displayed as NASDAQ: LIFE.

What is the 52 week high and low for aTYR PHARMA (NASDAQ: LIFE)?

(NASDAQ: LIFE) aTYR PHARMA's 52-week high was $13.10, and its 52-week low was $2.93. It is currently -21.76% from its 52-week high and 249.83% from its 52-week low.

How much is aTYR PHARMA stock worth today?

(NASDAQ: LIFE) aTYR PHARMA currently has 16,919,872 outstanding shares. With aTYR PHARMA stock trading at $10.25 per share, the total value of aTYR PHARMA stock (market capitalization) is $173.43M.

aTYR PHARMA stock was originally listed at a price of $209.30 in May 7, 2015. If you had invested in aTYR PHARMA stock at $209.30, your return over the last 6 years would have been -95.1%, for an annualized return of -39.51%.

How much is aTYR PHARMA's stock price per share?

(NASDAQ: LIFE) aTYR PHARMA stock price per share is $10.25 today (as of Sep 24, 2021).

What is aTYR PHARMA's Market Cap?

(NASDAQ: LIFE) aTYR PHARMA's market cap is $173.43M, as of Sep 26, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

aTYR PHARMA's market cap is calculated by multiplying LIFE's current stock price of $10.25 by LIFE's total outstanding shares of 16,919,872.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.